Carregant...
Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
OBJECTIVES: To characterise the use of the parenteral non-steroidal anti-inflammatory drug parecoxib when given by continuous subcutaneous infusion (CSCI) in a hospice population. Clinical experience suggests parecoxib CSCI may be of benefit in this population, but empirical evidence in relation to...
Guardat en:
| Publicat a: | BMJ Support Palliat Care |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867430/ https://ncbi.nlm.nih.gov/pubmed/28864447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjspcare-2017-001348 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|